Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta

Journal of Anatomy

Volumn 194, Issue 2, 1999, Pages 183-195

  Hu, Zhao Yuan ^a   Liu, Yi Xun ^a   Liu, Kui ^a,c   Byrne, Simon ^b   Ny, Tor ^c   Feng, Qiang ^b   Ockleford, Colin D ^b  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Placentation; Pregnancy; Trophoblast

Indexed keywords

ANTIBODY; COMPLEMENTARY RNA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL TISSUE; ARTICLE; CHILDBIRTH; CHORION; CONNECTIVE TISSUE CELL; CYTOTROPHOBLAST; DECIDUA; ENDOMETRIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; MESENCHYME; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; RHESUS MONKEY; SPECIES DIFFERENCE; STROMA CELL; TROPHOBLAST;

ANIMALS; DECIDUA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU HYBRIDIZATION; MACACA MULATTA; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PLACENTA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREGNANCY, ANIMAL; TISSUE PLASMINOGEN ACTIVATOR; TROPHOBLASTS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; MACACA MULATTA;

EID: 0032936444     PISSN: 00218782     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0021878298004506     Document Type: Article

References (51)

1. ÅSTEDT B, LECANDER I, NY T (1987) The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1, 203.
2. BLASI F, VASSALLI JD, DANO K. (1987) Urinokinase-type plasminogen activator: proenzyme, receptor and inhibitors. Journal of Cell Biology 104, 801-804.
3. BRADBURY FM, OCKLEFORD CD (1990) A confocal and conventional epifluorescence microscope study of intermediate filaments in chorionic villi. Journal of Anatomy 169, 173-187.
4. CASTELLUCCI M, CRESCIMANNO C, SCHRÖTER CA, KAUFMANN P, MÜHLHAUSER J (1993) Extravillous trophoblast: immunohistochemical localisation of extracellular matrix molecules. In Frontiers in Gynecologic and Obstetric Investigation (ed. Genazzani AR, Petraglia F, Genazzani AD), pp. 19-25. New York: Parthenon.
5. COLEMAN RW, MARDER UJ, SALZMAN EW, HIRSCH J (1987) Overview of haemostasis. In Hemostasis and Thrombosis 2nd edn (ed. Coleman RW, Hirsch J, Marder UJ, Salzman EW), pp. 3-17. Philadelphia: Lipincott.
6. CHOMCZYNSKI P, SACCHI N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
7. DEBOER K, LECANDER I, TEN CATE JW, BORM JJ, TREFFERS PE (1988) Placental-type plasminogen activator inhibitor in preeclampsia. American Journal of Obstetrics and Gynecology 158, 518-522.
8. ESTELLES A, GILABERT J, AZNAR J, LOSKUTOFF DJ, SCHLEEF RR (1989) Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 74, 1332-1338.
9. ESTELLES A, GILABERT J, KEETON M, EGUCHIY, AZNAR J, GRANCHA S et al. (1994). Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84, 143-150.
10. FAZLEABAS AT, EVERLY SL, LOTTENBERG R (1991) Immunological and molecular characterization of plasminogen activator inhibitor 1 and 2 in baboon (Papio anubis) placental tissues. Biology of Reproduction 45, 49-56.
11. FEINBERG RF, KAO L-C, HAIMOWITZ JE, QUEENAN JT JR, WUN TC, STRAUSS JF, III et al. (1989) Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Laboratory Investigation 61, 20-26.
12. FEINBERG RF, KLIMAN HJ, LOCKWOOD CJ (1991) Is oncofetal flbronectin a trophoblast glue for human implantation? American Journal of Pathology 138, 537-543.
13. FISHER SJ, LEITCH MS, KANTOR MS (1985) Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas. Journal of Cell Biochemistry 27, 31-41.
14. FISHER SJ, CUI T-Y, ZHANG L, HARTMAN L, GRAHL K, ZHANG G-Y et al. (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. Journal of Cell Biology 109, 891-902.
15. FRANK H-G, MALEKZADEH F, KERTSCHANSKA S, CRESCIMANNO C, CASTELLUCCI M, LANG, I et al. (1994) Immunohistochemistry of two different types of placental fibrinoid. Acta Anatomica 150, 55-68.
16. GOW L, CAMPBELL DM, OGSTON D (1984) The fibrinolytic system in pre-eclampsia. Journal of Clinical Pathology 37, 56-58.
17. HAMILTON WJ, BOYD JD (1960) Development of the human placenta in the first three months of gestation. Journal of Anatomy 94, 297-328.
18. HOFMANN GE, GLATSTEIN I, SCHATZ F, HELLER D, DELIGDISCH L (1994) Immunohistochemical localization of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 and 2 in early human implantation sites. American Journal Obstetrics and Gynecology 170, 671-676.
19. JONASSON A, LARSSON B, LECANDER I, ÅSTEDT B (1989) Placental and decidual u-PA, t-PA, PAI-1 and PAI-2 concentrations, as affected by cervical dilatation with laminaria tents or Hegar dilators. Thrombosis Research 53, 91-97.
20. JORGENSEN M, PHILIPS M, THORSEN S, SELMER J, ZEUTHEN J (1987) Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Thrombosis and Haemostasis 58, 872-878.
21. KAWANO T, MORIMOTO K, UEMURA Y (1968) Urokinase inhibitor in human placenta. Nature, 217, 253-254.
22. KRUITHOF EK, TRAN-THANG C, GUDINCHET A, HAUERT J, NICOLOSO G, GENTON C et al. (1987) Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 69, 460-466.
23. LECANDER I, ÅSTEDT B (1987) Specific plasminogen activator inhibitor of placental type PAI-2 occurring in amniotic fluid and cord blood. Journal of Laboratory and Clinical Medicine 110, 602-605.
24. LIBRACH CL, WERB Z, FITZGERALD ML, KING CHIU, CORWIN NM, ESTEVES RA et al. (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. Journal of Cell Biology 113, 437-449.
25. LIOTTA LA, GOLDFARB RH, BRUNDAGE R, SIEGAL GP, TERRANOVA V, GARBISA S (1981) Effect of plasminogen activators (urokinase), plasmin and thrombin on glycoprotein and collagenous components of the basement membrane. Cancer Research 41, 4629-4636.
26. LIU YX, HU ZY, ZOU RJ, OCKLEFORD CD (1997) Identification of secretion sites of tissue plasminogen activator and plasminogen activator inhibitor type-1 in basal plates of human and rhesus monkey placentae. Chinese Science Bulletin 42 1030-1033.
27. LIU YX, HU ZY, BYRNE S, ZOU RJ, NY T, D'LACEY C et al. (1998) Localisation and distribution of tissue type and urokinase type plasminogen activators and inhibitors Type 1 and Type 2 in human and rhesus monkey fetal membranes. Placenta 19, 171-180.
28. LOSKUTOFF DJ (1991) Regulation of PAI-1 gene expression. Fibrinolysis 5, 197-206.
29. MACKAY AR, CORBITT RH, HARTZLER JL, THORGEIRSSON, UP (1990) Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Research 50, 5997-6001.
30. MARTIN O, ARIAS F (1982) Plasminogen activator production by trophoblast cells in vitro: effect of steroid hormones and protein synthesis inhibitors. American Journal of Obstetrics and Gynecology 142, 402-409.
31. MEEKINS JW, PIJNENBORG R, HANSSENS M, MCFADYENIR, VAN ASSCHE A (1994) A study of placental bed spiral arterioles and trophoblast invasion in normal and severe pre-eclampsia pregnancies. British Journal of Obstetrics and Gynecology 101, 669-674.
32. NANAEV AK, MILOVANOV AP, DOMOGATSKY SP (1993) Immunohistochemical localization of extracellular matrix in perivillous fibrinoid of normal human term placenta. Histochemistry 100, 341-346.
33. NILSSON IM, FELDING P, LECANDER I, LENNER C, ÅSTEDT B (1986) Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women. British Journal of Haematology 62, 215-220.
34. NITABUCH R (1887) Beiträge zur Kenntniss der menschlichen Placenta. Doctoral Thesis, University of Bern, Stämpflische Buchdruckerei.
35. NY T, SAWDEY M, LAWRENCE DA, MILLAN JL, LOSKUTOFF DJ (1986) Cloning and sequence of a cDNA coding for the human β-migrating endothelial cell-type plasminogen activator inhibitor. Proceedings of the National Academy of Science of the USA 83, 6776-6780.
36. NY T, HANSSON L, LAWRENCE D, LEONARDSSON G, ÅSTEDT B (1989) Plasminogen activator inhibitor type-2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted. Fibrinolysis 3, 189-196.
37. OCKLEFORD CD, MALAK T, HUBBARD ARD, BRACKEN K, BURTON S-A, BRIGHT NA et al. (1993) Confocal and conventional immunofluorescence and ultrastructural localisation of intracellular strength giving components of human amniochorion. Journal of Anatomy 183, 483-505.
38. OCKLEFORD CD, MONGAN LC, HUBBARD ARD (1997) Techniques of advanced light microscopy and their applications to morphological analysis of human extra-embryonic membranes. Microscopy Research and Technique 38, 153-164.
39. PENNICA D, HOLMES WE, KOHR WJ, HARKINS RN, VEHAR GA, WARD CA et al. (1982) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301, 214-221.
40. PIJNENBORG R, DIXON G, ROBERTSON X (1980) Trophoblastic invasion of the human decidua from 8 to 18 weeks of pregnancy. Placenta 1, 3.
41. PIJNENBORG R, ANTHONY J, DAVEY DA, REES A, TILTMAN A, VERCRUYSSE L et al. (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. British Journal of Obstetrics and Gynaecology 88, 648-655.
42. ROHR K (1889) Die Beziehungen der mütterlichen Gefässe zu den intervillösen Räumen der reifen Placenta speciell zur Thrombose derselben ("weisser Infarct"). Virchow's Archives, Pathological Anatomy 115, 505-534.
43. SAKSELA O (1985) Plasminogen activation and the regulation of pericellular proteolysis. Biochimica Biophysica Acta 823, 35-65.
44. SCHNEIDERMAN J, LOSKUTOFF DJ (1991) Plasminogen activator inhibitor. Trends in Cardiac Medicine 1, 99-107.
45. SCHAEREN-WIEMERS N, GERFIN-MOSER A (1993) A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in-situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431-440.
46. VASSALLIJD, SAPPINO AP, BELIN D (1991) The plasminogen activator/plasmin system. Journal of Clinical Investigation 88, 1067-1072.
47. VERDE P, STOPPELLI MP, GALEFFI P, DINOCERA P, BLASI F (1984) Identification and primary sequence of an unspliced human urokinase Poly(a) + tRNA. Proceedings of the National Academy of Science of the USA 81, 4727-4731.
48. WIMAN B, CSEMICZKY G, MARSK L, ROBBE H (1984) The fast-acting inhibitor of tissue plasminogen activator in plasma during pregnancy. Thrombosis and Haemostasis 52, 124-126.
49. WUN T-C, REICH E (1987) An inhibitor of plasminogen activation from human placenta. Purification and characterization. Journal of Biological Chemistry 262, 3646-3653.
50. YAGEL S, PARHAR RS, JEFFREY JJ, LALA PK (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. Journal of Cell Physiology 136, 455-462.
51. YE RD, WUN T-C, SADLER JE (1987) cDNA cloning and expression in E coli of a plasminogen activator inhibitor from human placenta. Journal of Biological Chemistry 262, 3718-3725.